Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.275
+0.075 (1.79%)
At close: Jun 26, 2026, 4:00 PM EDT
4.400
+0.125 (2.92%)
After-hours: Jun 26, 2026, 4:51 PM EDT
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 29 or -55.77% compared to the previous year.
Employees
23
Change (1Y)
-29
Growth (1Y)
-55.77%
Revenue / Employee
$282,565
Profits / Employee
-$1,286,087
Market Cap
8.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Curis | 24 |
| AIM ImmunoTech | 21 |
| MetaVia | 8 |
| Immuron | 7 |
| Quoin Pharmaceuticals | 6 |
| Cadrenal Therapeutics | 5 |
| Kairos Pharma | 4 |
BOLT News
- 14 days ago - Bolt Metals Announces Closing of Option to Acquire the High-Grade Floralia Iron Project - Accesswire
- 4 weeks ago - Bolt Biotherapeutics initiated with a Buy at Rodman & Renshaw - TheFly
- 6 weeks ago - Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Bolt Biotherapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Bolt Biotherapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Bolt Biotherapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Bolt Biotherapeutics Proxy statement: Proxy filing - Filings
- 3 months ago - Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52) - TheFly